STAT+: Government warns Medicare Advantage insurers not to deny care based on AI
In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot…
Category: Business
The GLP-1 panic is alive and well
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Vertex still knows how to do what it does best
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Regeneron is interested in obesity treatments that combat muscle loss
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: New Medicare Advantage rule is boon for providers, drag on insurers
Starting this year, private Medicare plans have to cover their members’ hospitalizations at the higher…
What makes a drug a blockbuster — or a cautionary tale?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Novavax is on thin ice, and the latest update isn’t exactly encouraging
Want to stay on top of the science and politics driving biotech today? Sign up to…
.jpg)
Pfizer’s reset year starts with a little profit
Want to stay on top of the science and politics driving biotech today? Sign up to get…
How an immunological Trojan horse could treat disease
Want to stay on top of the science and politics driving biotech today? Sign up to get…
23andMe breach targeted Chinese, Jewish populations
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Eli Lilly overtakes Tesla in market value
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: CVS wants to become a medical powerhouse. Will long lines and understaffing hold it back?
CVS Health is perhaps best known for two things. First, there are the comically long…
Another step toward new drugs for Parkinson’s
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: A PBM in Africa flips the industry’s script in a bid to make people healthier
WASHINGTON — For an app that helps pharmacies in Africa manage their medicines, the term…
Lilly’s gene therapy restores hearing in an 11-year-old, paving way for more treatment
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
STAT+: A for-profit health system’s financial issues could plunge overburdened hospitals into crisis
Steward Health Care, a for-profit health system that serves thousands of patients in Eastern Massachusetts,…
Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Medicare Advantage update pushes Wall Street to reset expectations
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
Investigators fault Lilly plant for manufacturing issues
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The Senate health committee looks into its first subpoena in 40 years
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Hospitals offer their custom-built tech for sale in search of new revenue streams
Hospitals aren’t usually in the business of selling technology tools. But that’s changing thanks to…
STAT+: Microsoft to embed AI tool for clinical documentation in Epic’s health records software
Microsoft on Thursday said it will launch its artificial intelligence tool for automating clinical documentation…
STAT+: Apple removes pulse oximeter feature in Watches to comply with ban
Apple will remove the blood oxygen measurement feature from its Apple Watches, the company announced…
The XBI comedown after JPM
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: How digital therapeutics companies are improvising when insurance coverage isn’t guaranteed
For years, the playbook for many companies that wanted to market digital therapeutics was stupid…
Pumping breastmilk in bathrooms is a common, albeit unspoken, practice at health care conferences
Even though Erin Booth was not thrilled about having to travel to Philadelphia for a…
General Catalyst to buy Ohio-based health system Summa Health
Venture capital firm General Catalyst has agreed to acquire Ohio-based nonprofit health system Summa Health…
The big any-day-now biotech news we’re keeping an eye on
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: More patients are getting their meds online. Big Pharma wants in on the action
Since the pandemic, patients have become increasingly comfortable with getting their medications online. Direct-to-consumer telehealth…
STAT+: At health care’s biggest investor conference, AI’s high hopes collided with skepticism
You didn’t need machine learning to make one prediction about the year’s biggest conference for…
Opinion: The decline and fall of elite multispecialty medical groups
The failure of Geisinger Health System, which lost $842 million in 2022 and disappeared into…
The four biotech stories you need to read this morning
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Could private equity be the future of private practice? A new lobbying group thinks so
Private equity gets a bad rap in health care. But some doctors see that kind…
Novartis reportedly decides to pass on Cytokinetics
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The highs — and lows — of JPM 2024 you should pay attention to
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
STAT+: Rune Labs, which makes an app to track Parkinson’s symptoms, raises $12 million
Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s…
JPM Day 3 had a cautiously optimistic outlook
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
JPM Day 2 has arrived. Here are the can’t-miss moments of the event so far
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
STAT+: Mayo Clinic partners with supercomputing startup Cerebras to build custom AI tools
SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first…
This is the TLDR of JPM Day 1
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The…
UnitedHealth’s next physician acquisition & the January health insurance churn
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
STAT+: CVS Health sees Medicare Advantage patients seek more care, eating into profits
Medicare Advantage members continue to go to the doctor and get health care procedures a…
STAT+: Walgreens isn’t acquiring anytime soon, per CEO
Between Walgreens’ earnings call last week and its J.P. Morgan Healthcare Conference presentation on Monday,…
STAT+: Boston Scientific acquires Axonics, urology company, for $3.7 billion
Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders,…
STAT+: What to expect from hospitals and health insurers at this year’s JPM Healthcare Conference
Nonprofit hospitals often get overshadowed at the J.P. Morgan Healthcare Conference, the health care industry’s…
Why CG Oncology will be the first test of 2024’s IPO waters
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Anavex’s slow journey to failure
Want to stay on top of the science and politics driving biotech today? Sign up to get…
UnitedHealth’s rehab restrictions, Texas medical school drama, and health care’s biggest profits
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of…
STAT+: UnitedHealth used secret rules to restrict rehab care for seriously ill Medicare Advantage patients
Health insurance giant UnitedHealth Group used secret rules to restrict access to rehabilitation care requested…
STAT+: Complications spiked 25% in hospitals bought by private equity
There’s ample evidence that private equity buyouts in health care drive up costs. A new…